Lescuyer Laboratory   Report issue

For profit
Founded: Aytre France (1994)
Status: No NME R&D (1994)

Organization Overview

First Clinical Trial
2008
NCT01354327
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 5
  • # of Trial APIs: 11